Stockholders' Equity
 9 Months Ended
Nov. 30, 2018
Notes to Financial Statements  
Note 7. Stockholders' Equity

Common Stock

 

For the nine months ended November 30, 2018   Number of shares     Amount  
Balance, February 28, 2018     33,751,088     $ 3,376  
Cashless exercise of warrants     18,821       2  
Issuance of shares upon vesting of restricted stock units     35,797       3  
Balance, November 30, 2018     33,805,706     $ 3,381  

 

During the nine months ended November 30, 2018, the Company issued 18,821 shares of common stock upon the cashless exercise of 20,000 warrants and 35,797 shares of common stock upon issuance of restricted stock units.

 

During the nine months ended November 30, 2017, the Company sold, under a private placement, 1,123,266 shares of its common stock at an offering price of $5.25 and 18,128 of its common stock at an offering price of $12.00, resulting in proceeds to the Company of $6,114,724. During the nine months ended November 30, 2017, the Company issued 20,000 shares of common stock upon the cashless exercise of 22,919 warrants and 193,770 shares of its common stock upon the exercise of warrants at an offering price of $6.00 per share, resulting in proceeds of $1,163,016.